Pune, India — 01/12/2018 — Organ transplantation is one of the great advances in the modern day medicine. Organ transplantation is a medical procedures in which an organ is removed from one body and transferred to another body, to replace the missing or damaged organ. One of the most important aspect of the organ transplantation is the consent of the patient himself or the family of the patient. Organ harvesting without proper consent is illegal and a massive crime. The major driving factor for the Organ Transplantation Market are increasing prevalence of number of chronic diseases and organ failure. Global Organ Transplantation Market is expected to grow at a CAGR of 9.8% during forecasted period 2017-2023.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/915 .
Organ transplantation is mostly carried out with the brain dead patient who's other organs are healthy and can be used to save another person's life. The process of organ transplantation needs to be done right after the death of the patient until couple of hours. This procedure is performed to treat organ failures in lungs, liver, kidney and many more. Kidney is the most widely transplanted organ which is followed by liver. Unfortunately, the need for organ donors is much higher than the number of people who donate organs. According to National Kidney Foundation, more than 3,000 new patients are added to the kidney waiting list each month worldwide. According to United Network for organ sharing, in United States everyday 21 people die waiting for an organ, and more than 120,000 men, women, and children await lifesaving organ transplants. Increasing prevalence of renal diseases, over consumption of alcohol and unhealthy diet has provided push for the growth of the market. Whereas, high cost of transplantation, limited number of donor and increasing incident of organ failure has restrained the growth of the market.
Top Market Players of Organ Transplantation Market:
Novartis International AG (Switzerland), Terumo Medical Corporation (US), Transonic (US), F. Hoffmann-La Roche Ltd. (Switzerland), Astellas Pharma, Inc (Japan), Preservation Solutions, Inc. (US), OrganOX Limited (UK), Bio Med Pvt. Ltd. (US), Transplant Biomedical (UK), TransMedic, Inc. (US), Accord Healthcare GmbH (Spain), Sanofi (France), Pfizer, Inc. (US), Veloxis Pharmaceuticals A/S (Denmark), GlaxoSmithKline Plc. (UK)
Order Copy of 80 Premium Pages is Available @ https://www.marketresearchfuture.com/reports/organ-transplantation-market-915 .
Organ Transplant Market – Segments
Global Organ Transplant Market is segmented in to 4 Key dynamics for an easy grasp and enhanced understanding.
Segmentation by Types: Comprises – Kidney, Liver, Heart, Lungs and other.
Segmentation by Products: Comprises – Instruments, Software and Commercialized products (Zenapax, Prograf, Cellcept, Myfortic, Neoral)
Segmentation by End Users: Comprises – Hospitals, Transplant Centers and Research Laboratories and other.
Segmentation by Regions: Comprises Geographical regions – North America, Europe, APAC and Rest of the World.
Market Factor Analysis
Global Organ Transplantation Market, By Type of Organ
Global Organ Transplantation Market, By Products
Global Organ Transplantation Market, By Type of Transplant
Global Organ Transplantation Market, By Treatment
Global Organ Transplantation Market, By End User
Global Organ Transplantation Market, By Region
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/915 .
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Powered by WPeMatico